Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
64.3M
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
20.4M
-
Shares change
-
+909K
-
Total reported value, excl. options
-
$278M
-
Value change
-
+$7.85M
-
Number of buys
-
25
-
Number of sells
-
-14
-
Price
-
$13.61
Significant Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) as of Q2 2022
53 filings reported holding VERA - Vera Therapeutics, Inc. - COMMON STOCK as of Q2 2022.
Vera Therapeutics, Inc. - COMMON STOCK (VERA) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.4M shares
of 64.3M outstanding shares and own 31.7% of the company stock.
Largest 10 shareholders include FMR LLC (4.02M shares), Sofinnova Investments, Inc. (3.18M shares), Abingworth LLP (2.96M shares), CITADEL ADVISORS LLC (2.12M shares), RA CAPITAL MANAGEMENT, L.P. (1.58M shares), Kynam Capital Management, LP (1.52M shares), BlackRock Inc. (717K shares), VANGUARD GROUP INC (677K shares), Vivo Capital, LLC (667K shares), and Octagon Capital Advisors LP (575K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.